Back to Previous Page

Iron oxide (II,III), nanoparticles 30 nm avg. part. size (TEM), streptavidin functionalized, 1 mg/mL in H2O

ITEM#: 3042-9001481ML

MFR#: 900148-1ML

Recent docking studies highlight the potential interaction of iron oxide (II,III) nanoparticles (IONPs) with the SARS-CoV-2 spike protein receptor binding domain. This may target viral entry in host cells and also render virions inactive.

Recent docking studies highlight the potential interaction of iron oxide (II,III) nanoparticles (IONPs) with the SARS-CoV-2 spike protein receptor binding domain. This may target viral entry in host cells and also render virions inactive.